Low expression of PRMT5 in peripheral blood may serve as a potential independent risk factor in assessments of the risk of stable CAD and AMI

BACKGROUND: Protein arginine methyltransferases (PRMTs) can catalyse the methylation of arginine and participate in many important cellular reaction processes. The purpose of this research is to determine whether the expression levels of the PRMT5 gene in peripheral blood can be used as a biomarker...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cardiovasc Disord
Autori principali: Tan, Buchuan, Liu, Qian, Yang, Liping, Yang, Yushuang, Liu, Dongna, Liu, Long, Meng, Fanbo
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6357489/
https://ncbi.nlm.nih.gov/pubmed/30704408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-019-1008-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi